Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Sugammadex Sodium Patent Expiration

Sugammadex Sodium is Used for reversing drug-induced neuromuscular blockage. It was first introduced by Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc in its drug Bridion on Dec 15, 2015. 5 different companies have introduced drugs containing Sugammadex Sodium.


Sugammadex Sodium Patents

Given below is the list of patents protecting Sugammadex Sodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Bridion USRE44733 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block Jan 27, 2026 Msd Sub Merck
Bridion US6949527 6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block Jan 27, 2021

(Expired)

 Msd Sub Merck
Bridion US7265009 HDP-CVD methodology for forming PMD layer Aug 07, 2020

(Expired)

 Msd Sub Merck
Bridion US7265099 Use of chemical chelators as reversal agents for drug-induced neuromuscular block Aug 07, 2020

(Expired)

 Msd Sub Merck



Sugammadex Sodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sugammadex Sodium Generic API Manufacturers

Several generic applications have been filed for Sugammadex Sodium. The first generic version for Sugammadex Sodium was by Aspiro Pharma Ltd and was approved on Jun 9, 2023. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Oct 4, 2023.

Given below is the list of companies who have filed for Sugammadex Sodium generic, along with the locations of their manufacturing plants worldwide.


1. ASPIRO

Aspiro Pharma Ltd has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

solution Prescription INTRAVENOUS AP Jun 9, 2023
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)

solution Prescription INTRAVENOUS AP Jun 9, 2023


Manufacturing Plant Locations
New

Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.

Country City Firm Name
India
Siddipet (Dist) Aspiro Pharma Limited





2. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)

solution Prescription INTRAVENOUS AP Jun 15, 2023
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

solution Prescription INTRAVENOUS AP Jun 15, 2023


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Rockford Mylan Institutional, Inc.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos Mylan Pharmaceuticals Inc.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Morgantown Mylan Specialty, L.P.
Saint Albans Mylan Technologies, Inc.
Greensboro Mylan Pharmaceuticals Inc
India
Hyderabad Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





3. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)

solution Prescription INTRAVENOUS AP Jun 23, 2023
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

solution Prescription INTRAVENOUS AP Jun 23, 2023


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited





4. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)

solution Discontinued INTRAVENOUS N/A Oct 4, 2023
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

solution Discontinued INTRAVENOUS N/A Oct 4, 2023